Lymphoma Clinical Trials in San Diego

Showing 261-280 of 326 trials

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

NCT00726934

The purpose of this study is to determine if FDA approved food safety guidelines are equivalent to a low bacterial diet (the neutropenic diet) with respect to the acquisition of infections during neutropenia in a sample of pediatric cancer patients.

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaNon-Hodgkins Lymphoma+2 more

Indiana University149 participantsStarted Sep 2007

San Diego, California, United States • Indianapolis, Indiana, United States • Brooklyn, New York, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

NCT00053053

RATIONALE: Nutritional supplements may help prevent loss of appetite, weight loss, and fatigue in patients with advanced cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two nutritional supplements in preventing loss of appetite, weight loss, and fatigue in patients who have stage III or stage IV solid tumors.

CachexiaLymphomaLymphoproliferative Disorder+1 more

Radiation Therapy Oncology Group472 participantsStarted Dec 2002

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +247 more locations

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

Lymphoma Trials in Other Cities

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment

A Safety Study of SGN-CD19A for B-Cell Lymphoma

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1

A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)

Other Conditions in San Diego